Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Berger

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Zeitschrift Fur Geburtshilfe Und Neonatologie|December 5, 2019
[Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes]Richard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|August 20, 2019
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm BirthRichard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Correction: Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm BirthRichard Berger, Harald Abele, Franz Bahlmann, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|October 18, 2019
[Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth]Richard Berger, Harald Abele, Franz Bahlmann, et al.
Journal of Medicinal Chemistry|December 29, 2015
Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive BladderScott D Edmondson, Cheng Zhu, Nam Fung Kar, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2015
Development of a novel tricyclic class of potent and selective FIXa inhibitorsDongfang Meng, Patrick Andre, Thomas J Bateman, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Zeitschrift Fur Geburtshilfe Und Neonatologie|December 5, 2019
[Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes]Richard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|August 20, 2019
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm BirthRichard Berger, Harald Abele, Franz Bahlmann, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Correction: Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm BirthRichard Berger, Harald Abele, Franz Bahlmann, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|October 18, 2019
[Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth]Richard Berger, Harald Abele, Franz Bahlmann, et al.
Journal of Medicinal Chemistry|December 29, 2015
Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive BladderScott D Edmondson, Cheng Zhu, Nam Fung Kar, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2015
Development of a novel tricyclic class of potent and selective FIXa inhibitorsDongfang Meng, Patrick Andre, Thomas J Bateman, et al.
Pageof 8